Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

By the Numbers: Covid-19 Edition

A collection of facts and figures surrounding the COVID-19 pandemic
Spring/Summer 2020

By the Numbers

A collection of workers’ compensation facts and figures
Winter 2019/2020

State of the States

A roundup of regulatory activity around the country
Winter 2019/2020

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

More States Consider Cancer Presumptions for Firefighters

Different types of cancers are being added to pre-existing presumptions.
Apr 2024

Visit Healthesystems at RISKWORLD 2024

Pick up a copy of the new Summer 2024 edition of RxInformer magazine, and learn how Healthe is transforming healthcare.
Apr 2024

New Autoimmune Biosimilar Approved and Alzheimer’s Drug Goes Generic

Simlandi injection was approved for arthritic conditions, while Namzaric receives its first generic approval.
Mar 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.
Aug 2018

JAMA Study Questions the Effectiveness of Negative Pressure Wound Therapy

In a randomized clinical trial of 460 patients, researchers found the treatment to have similar impact on self-rated disability as standard wound dressing.
Jul 2018

IQVIA Reports on Global Oncology Trends

Global spending on cancer therapies now exceeds $133 billion.
Jun 2018
1 22 23 24 25 26

Whitepapers

lockmap-markermagnifiercrossmenucross-circle